Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Kouhei Tsuchida(Tohoku University), Tadayuki Tsujita(Tohoku University), Makiko Hayashi(Tohoku University), Asaka Ojima(Tohoku University), Nadine Keleku-Lukwete(Tohoku University), Fumiki Katsuoka(Tohoku Medical Megabank Organization), Akihito Otsuki(Tohoku Medical and Pharmaceutical University), Haruhisa Kikuchi(Tohoku University), Yoshiteru Oshima(Tohoku University), Mikiko Suzuki(Tohoku University), Masayuki Yamamoto(Tohoku University)
Cited by 166
Abstract
Related Papers
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
Ken Itoh, Tomoki Chiba, Satoru Takahashi et al.|Biochemical and Biophysical Research Communications|1997|3.9k